FiveT Fintech

LimeWire is a digital collectibles marketplace focused on the music, art, and entertainment industries. The platform has been relaunched to transform the way fans and artists interact, providing a framework for direct fan membership that helps artists generate a recurring revenue stream. LimeWire enables users to explore, collect, and trade unique digital collectibles, including NFTs, while keeping them informed with timely announcements within the art and entertainment space. Fans gain access to exclusive content and a private community, allowing them to connect directly with their favorite artists and participate actively in their journeys.

Tenity is a global innovation ecosystem and early-stage investor based in Zurich, Switzerland, founded in 2015. The firm operates as an accelerator and incubator, concentrating on companies within the technology sectors. With a mission to shape the future of finance and beyond, Tenity supports startups by providing resources, mentorship, and investment to foster innovation and growth in the evolving technological landscape.

ZELF is a neobank fintech company that aims to make financial services accessible to younger generations globally. Operating in both the EU and the US, ZELF allows users to access banking services through popular social messaging platforms, including WhatsApp, Facebook Messenger, Discord, Telegram, and Viber. The company focuses on providing a seamless money-transfer platform that supports artificial intelligence-powered voice control, enabling users to send and receive money, create invoices, and manage reminders for unpaid transactions easily. In June 2022, ZELF launched its "Bank of the Metaverse" campaign, integrating traditional fiat currency with game loot and NFTs, further enhancing its innovative banking offerings.

PreComb is a technology company focused on enhancing cancer treatment outcomes through innovative solutions tailored for difficult-to-treat cancers. The company has developed a 3D drug testing technology that utilizes automated microtumor-based profiling for in vitro cancer diagnosis. This technology enables clinical institutions to conduct on-site evaluations, allowing for the functional assessment of various cancer drugs, combinations, and concentrations using patient-derived micro-tumors. By optimizing the selection of therapies, PreComb aims to improve success rates in cancer treatment and ultimately enhance the quality of life for patients.